These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2876514)

  • 1. Episodic and residual thought pathology in chronic schizophrenics: effect of neuroleptics.
    Spohn HE; Coyne L; Larson J; Mittleman F; Spray J; Hayes K
    Schizophr Bull; 1986; 12(3):394-407. PubMed ID: 2876514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thought pathology in manic and schizophrenic patients. Its occurrence at hospital admission and seven weeks later.
    Harrow M; Grossman LS; Silverstein ML; Meltzer HY
    Arch Gen Psychiatry; 1982 Jun; 39(6):665-71. PubMed ID: 6124224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenic thinking and neuroleptic dosage.
    Puente AE; Andersson C
    J Clin Psychol; 1987 Mar; 43(2):189-97. PubMed ID: 2883201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of clinical response to different kinds of neuroleptics in first time medicated schizophrenics.
    Kadota K
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):127-53. PubMed ID: 1353124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics.
    Smith RC; Baumgartner R; Ravichandran GK; Largen J; Calderon M; Burd A; Mauldin M
    Acta Psychiatr Scand; 1987 Jan; 75(1):11-9. PubMed ID: 2883814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thought disorder. The measurement of its changes.
    Hurt SW; Holzman PS; Davis JM
    Arch Gen Psychiatry; 1983 Dec; 40(12):1281-5. PubMed ID: 6139992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls.
    Levy DL; Smith M; Robinson D; Jody D; Lerner G; Alvir J; Geisler SH; Szymanski SR; Gonzalez A; Mayerhoff DI
    Biol Psychiatry; 1993 Oct; 34(8):507-14. PubMed ID: 8274577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma free 3-methoxy-4-hydroxyphenylglycol in acute schizophrenics before and after treatment.
    Kaneko M; Honda K; Kanno T; Horikoshi R; Manome T; Watanabe A; Kumashiro H
    Neuropsychobiology; 1992; 25(3):126-9. PubMed ID: 1357582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
    Nagase Y; Okubo Y; Toru M
    Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of thought disorder in acute and chronic schizophrenia.
    Mazumdar PK; Chaturvedi SK; Gopinath PS
    Psychopathology; 1995; 28(4):185-9. PubMed ID: 7480574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction.
    Seidman LJ; Pepple JR; Faraone SV; Kremen WS; Green AI; Brown WA; Tsuang MT
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):575-84. PubMed ID: 8101100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth pursuit eye movements in schizophrenia: influences of neuroleptic treatment and the question of specificity.
    Küfferle B; Friedmann A; Topitz A; Földes P; Anderer P; Kutzer M; Steinberger K
    Psychopathology; 1990; 23(2):106-14. PubMed ID: 1979684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment.
    Biagiarelli M; Curto M; Di Pomponio I; Comparelli A; Baldessarini RJ; Ferracuti S
    Psychiatry Res; 2017 May; 251():294-297. PubMed ID: 28236781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased blink rates in schizophrenics. Influences of neuroleptics and psychopathology.
    Mackert A; Flechtner KM; Woyth C; Frick K
    Schizophr Res; 1991; 4(1):41-7. PubMed ID: 1672606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
    Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
    Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
    Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
    Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.